-
A Phase-1 Study Comparing Pharmacokinetic and Safety Profiles of Three Different Dose Intervals of Aripiprazole Lauroxil
By Robert Risinger, Marjie Hard, Peter J. Weiden
-
Alexander Bystritsky, MD Link
ORIGINAL RESEARCH
Efficacy of Duloxetine for the Treatment of Depression: Relationship to Most Recent Antidepressant Trial
Timothy Petersen, PhD, Roy H. Perlis, MD, Chris Ticknor, MD, Jim Lohr, MD, H. Brent Solvason, MD, PhD, John P. O’Reardon, MD, Madelaine M. Wohlreich, MD, Charissa Andreotti, ScB, Michael Wilson, MS, and Maurizio Fava, MD
-
A Pilot Study of the Pharmacodynamic Impact of SSRI Drug Selection and Beta-1 Receptor Genotype (ADRB1) on Cardiac Vital Signs in Depressed Patients: A Novel Pharmacogenetic Approach
By Kelan L.H. Thomas, Vicki L. Ellingrod, Jeffrey R. Bishop, Michael J. Keiser
-
Evidence-Based MedicineA Prospective Surveillance of Pharmacovigilance of Psychotropic Medicines in a Developing Country
By Jisha Myalil Lucca, Madhan Ramesh, Gurumurthy Parthasarathi, Dushad Ram
-
A Randomized, Placebo-Controlled Pilot Study of Quetiapine-XR Monotherapy or Adjunctive Therapy to Antidepressant in Acute Major Depressive Disorder with Current Generalized Anxiety Disorder
By Ranran Li, Renrong Wu, Jun Chen, David E. Kemp, Ming Ren, Carla Conroy, Philip Chan, Mary Beth Serrano, Stephen J. Ganocy, Joseph R. Calabrese, Keming Gao
-
A Review of Psychopharmacological Interventions Post-Disaster to Prevent Psychiatric Sequelae
By Badari Birur, Suresh Bada Math, Rachel E. Fargason
-
A Systematic Approach to Improving Care for Cancer Patients: Focus on Growth Factor Use and Outcomes
By Kimberly A. Bergstrom, PharmD, and Eric T. Herfindal, PharmD, MPH
-
ORIGINAL RESEARCHAddressing Methodological Issues in Studying Antidepressant Onset Efficacy Using Prespecified Sensitivity Analyses
By Ilya Lipkovich, PhD, Craig H. Mallinckrodt, PhD, Apurva Prakash, BA, and Andrew A. Nierenberg, MD
-
Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist
